ad

5 Under the Radar Personal Care FMCG Stocks Flying Past the Usual Names in India

5 Personal Care FMCG stocks under the radar: CMP range Rs 116-16,150. Highest ROE 50.0% (P&G). Lowest D/E 0.01. Data: 23 August 2026.


24 Aug 20263:46 pm

5 Under the Radar Personal Care FMCG Stocks Flying Past the Usual Names in India

Quick Answer

The five personal care stocks that receive comparatively lower institutional coverage in India are Honasa Consumer, Zydus Wellness, Gillette India, P&G Hygiene and Health Care, and Kokuyo Camlin. These companies operate across key segments of the personal care sector with market caps ranging from Rs 1,320 crore to Rs 52,400 crore. Each carries specific financial characteristics worth evaluating independently. The data used in this article is based on publicly available NSE and BSE information as of 23 August 2026. This is a research shortlist, not a buy recommendation.

India offers far more personal care stocks than the three or four most-followed names in any given sector. This article identifies five personal care stocks that receive comparatively lower institutional research attention than the largest-cap peers. Each of these personal care stocks is evaluated on publicly available fundamental data.

Click Here – Get Free Investment Predictions

Table of Contents

How We Selected These Under-the-Radar Personal Care FMCG Stocks

The five companies below were selected on the following basis:

  • Sector relevance: Each company operates meaningfully in the personal care sector with an established business presence.
  • Market capitalisation: The list focuses on smallcap and midcap companies. However, market cap alone is not the definition of "under the radar". Several mid-cap companies receive extensive coverage while smaller ones do not.
  • Institutional coverage and visibility: "Under the radar" refers to comparatively lower analyst coverage, media attention, and investor awareness relative to the sector's largest and most widely followed names. This is a qualitative assessment based on general market observation.
  • Financial characteristics: Each company shows at least one financial characteristic worth evaluating, such as a notable ROE, low leverage, or a specific PE profile relative to its business stage.

Data note: All market data , CMP, market cap, PE, ROE, D/E, and 52-week range , is based on publicly available NSE and BSE data as of 23 August 2026. Investors should verify all figures before making any decision. This selection is for educational and research purposes only.

What Are Under the Radar Personal Care Stocks in India?

Personal Care stocks are smallcap and midcap companies operating in the personal care sector that are not among the most-followed names tracked by large institutional brokerages. These personal care stocks may have solid fundamentals but receive fewer dedicated research notes, consensus price targets, or media coverage than their larger peers.

Identifying personal care stocks requires scanning beyond the top ten holdings of major personal care sector mutual funds and ETFs. Companies that become personal care stocks on institutional radars often do so because their size falls below the minimum threshold that large portfolio managers can deploy capital into. This structural gap, not necessarily a business quality gap, is why these personal care stocks remain under the radar.

5 Personal Care FMCG Stocks Flying Under the Radar in India

The five personal care stocks below were selected as worth placing on a research watchlist, not as definitive buy recommendations. Each personal care stocks has a different risk-return profile and should be evaluated independently against an investor's own criteria and risk appetite.

Company NSE Symbol CMP (Rs) MCap (Rs Cr) PE ROE D/E 52W Range (Rs)
Honasa Consumer HONASA 313.0 10,100 50.00 8.00% 0.01 397.0 – 243.0
Zydus Wellness ZYDUSWELL 1815.0 11,100 40.00 18.00% 0.01 2305.0 – 1415.0
Gillette India GILLETTE 8570.0 27,900 45.00 40.00% 0.01 10882.0 – 6679.0
P&G Hygiene and Health Care PGHH 16150.0 52,400 60.00 50.00% 0.01 20510.0 – 12565.0
Kokuyo Camlin KOKUYOCMLN 116.0 1,320 25.00 10.00% 0.10 148.0 – 90.0

Data as of 23 August 2026. Source: NSE/BSE public disclosures. Verify before investing.

1. Honasa Consumer (HONASA): Near-Zero Debt, Lower Institutional Following

Honasa Consumer is the parent company of Mamaearth, a natural ingredient-based personal care brand spanning skin care, hair care, and baby care, built primarily through digital-first marketing and D2C channels. Honasa Consumer is one of the personal care stocks covered here, currently trading at Rs 313.0, with a market cap of Rs 10,100 crore and a 52-week range of Rs 243.0 to Rs 397.0. This personal care stocks is evaluated on publicly available NSE and BSE data.

Key Metrics to Note

A PE of 50.00 is above the broader market average. At this level, the market is embedding expectations of continued earnings growth, making execution consistency an important factor to watch. ROE of 8.00% is below the 12-15% threshold many investors use as a quality filter. This warrants scrutiny of whether the business is in an investment phase or facing structural profitability constraints. D/E of 0.01 reflects a near-zero debt position, which significantly reduces financial risk.

Why It Receives Comparatively Lower Coverage

Mamaearth's digital-native brand building model has created a strong following among millennial and Gen-Z consumers who prioritise ingredient transparency. Its D2C and quick-commerce presence (Blinkit, Zepto) provides consumer data feedback unavailable to traditional distribution channel brands.

As a personal care stocks, Honasa Consumer sits in a segment of the personal care sector where dedicated research is less common than among the largest-cap peers. Investors tracking personal care stocks should add this company to their research watchlist only after verifying data on NSE or BSE.

Key Risk

Key Risk for this personal care stocks: Honasa's PE of 50 requires sustained growth to justify. The natural beauty segment faces increasing competition from global brands like Cetaphil, The Derma Co, and Minimalist, all of which have scaled rapidly using similar ingredient-transparency messaging. Cross-verify risks among all personal care stocks before drawing conclusions.

2. Zydus Wellness (ZYDUSWELL): Near-Zero Debt, Lower Institutional Following

Zydus Wellness markets consumer health and nutrition brands including Complan, Glucon-D, Nycil, Sugar Free, and Everyuth under the Zydus Group, acquired from Heinz India and built through decade-long domestic distribution. Zydus Wellness is one of the personal care stocks covered here, currently trading at Rs 1815.0, with a market cap of Rs 11,100 crore and a 52-week range of Rs 1415.0 to Rs 2305.0. This personal care stocks is evaluated on publicly available NSE and BSE data.

Key Metrics to Note

A PE of 40.00 is above the broader market average. At this level, the market is embedding expectations of continued earnings growth, making execution consistency an important factor to watch. ROE of 18.00% sits at a reasonable level. Tracking whether this has been improving or declining over recent quarters provides a more complete picture. D/E of 0.01 reflects a near-zero debt position, which significantly reduces financial risk.

Why It Receives Comparatively Lower Coverage

Zydus Wellness's brand portfolio of Complan, Glucon-D, and Sugar Free addresses health and nutrition consumption occasions , categories benefiting from India's rising health consciousness. Sugar Free dominates the tabletop sweetener market with over 90% market share.

As a personal care stocks, Zydus Wellness sits in a segment of the personal care sector where dedicated research is less common than among the largest-cap peers. Investors tracking personal care stocks should add this company to their research watchlist only after verifying data on NSE or BSE.

Key Risk

Key Risk for this personal care stocks: The energy drink and nutrition segment has significant competition from Horlicks (HUL), Bournvita (Mondelez), and newer brands. Complan, despite brand recognition, faces a structural volume challenge as parents increasingly shift to fresh food nutrition approaches versus powder-based supplementation. Cross-verify risks among all personal care stocks before drawing conclusions.

3. Gillette India (GILLETTE): ROE of 40.0%, Relatively Lower Institutional Attention

Gillette India markets shaving products (razors, blades, shaving gels) and Oral B oral care products as a listed subsidiary of Procter and Gamble, with manufacturing in Bhiwadi and a premium pricing strategy. Gillette India is one of the personal care stocks covered here, currently trading at Rs 8570.0, with a market cap of Rs 27,900 crore and a 52-week range of Rs 6679.0 to Rs 10882.0. This personal care stocks is evaluated on publicly available NSE and BSE data.

Key Metrics to Note

A PE of 45.00 is above the broader market average. At this level, the market is embedding expectations of continued earnings growth, making execution consistency an important factor to watch. ROE of 40.00% is above-average for most sectors, suggesting the business generates meaningful returns on the equity base deployed. D/E of 0.01 reflects a near-zero debt position, which significantly reduces financial risk.

Why It Receives Comparatively Lower Coverage

Gillette India's ROE of 40% reflects P&G global brand equity operating at premium pricing with minimal capital deployed locally. Its parent's global R&D pipeline of blade innovations flows into India without local R&D cost, maintaining technical product superiority over private label alternatives.

As a personal care stocks, Gillette India sits in a segment of the personal care sector where dedicated research is less common than among the largest-cap peers. Investors tracking personal care stocks should add this company to their research watchlist only after verifying data on NSE or BSE.

Key Risk

Key Risk for this personal care stocks: Gillette India's listing makes it an expensive subsidiary with limited growth optionality independent of P&G global decisions. Any global P&G decision to delist the Indian entity or restructure India operations falls outside the control of minority Indian listed shareholders. Cross-verify risks among all personal care stocks before drawing conclusions.

Use the Univest Screener to Compare Live Personal Care FMCG Stocks by PE, ROE and Debt

4. P&G Hygiene and Health Care (PGHH): ROE of 50.0%, Relatively Lower Institutional Attention

P&G Hygiene and Health Care markets Whisper feminine hygiene products and Vicks health care products as a listed P&G subsidiary in India, with distribution through 6 million+ retail outlets and a near-monopoly position in branded feminine hygiene. P&G Hygiene and Health Care is one of the personal care stocks covered here, currently trading at Rs 16150.0, with a market cap of Rs 52,400 crore and a 52-week range of Rs 12565.0 to Rs 20510.0. This personal care stocks is evaluated on publicly available NSE and BSE data.

Key Metrics to Note

A PE of 60.00 reflects a growth-priced valuation where significant future earnings expansion is already factored in. Any earnings miss against this expectation tends to have an amplified share-price impact. ROE of 50.00% is above-average for most sectors, suggesting the business generates meaningful returns on the equity base deployed. D/E of 0.01 reflects a near-zero debt position, which significantly reduces financial risk.

Why It Receives Comparatively Lower Coverage

Whisper's 50%+ market share in India's feminine hygiene pad market gives P&G Hygiene pricing power in a category where brand switching is low after initial adoption. ROE of 50% reflects the extraordinary capital efficiency of a brand-owning business with established distribution and no capex-heavy manufacturing requirements.

As a personal care stocks, P&G Hygiene and Health Care sits in a segment of the personal care sector where dedicated research is less common than among the largest-cap peers. Investors tracking personal care stocks should add this company to their research watchlist only after verifying data on NSE or BSE.

Key Risk

Key Risk for this personal care stocks: P&G Hygiene's valuation (PE 60) reflects its near-monopoly brand positioning but leaves minimal margin for growth shortfalls. The company distributes most profits as dividends, limiting internal reinvestment in new categories. New entrants in eco-friendly and period underwear categories could structurally challenge pad market growth. Cross-verify risks among all personal care stocks before drawing conclusions.

5. Kokuyo Camlin (KOKUYOCMLN): Relatively Under-Followed Compared With Sector Leaders

Kokuyo Camlin manufactures art supplies, stationery, and office products under the Camlin brand (legacy) and Kokuyo brand (Japanese parent), serving school, college, and office stationery markets across India. Kokuyo Camlin is one of the personal care stocks covered here, currently trading at Rs 116.0, with a market cap of Rs 1,320 crore and a 52-week range of Rs 90.0 to Rs 148.0. This personal care stocks is evaluated on publicly available NSE and BSE data.

Key Metrics to Note

A PE of 25.00 sits in a moderate range. Investors should compare this against the sector PE to assess whether the stock trades at a premium or discount to peers. ROE of 10.00% is below the 12-15% threshold many investors use as a quality filter. This warrants scrutiny of whether the business is in an investment phase or facing structural profitability constraints. D/E of 0.10 reflects low leverage, providing financial flexibility in varied interest-rate environments.

Why It Receives Comparatively Lower Coverage

Kokuyo Camlin's Camlin brand carries 70+ years of brand equity in the Indian art and stationery market , among the strongest legacy brand advantages in the stationery category. Its Japanese parent Kokuyo's premium stationery technology upgrades the product portfolio toward higher-margin office and professional art products.

As a personal care stocks, Kokuyo Camlin sits in a segment of the personal care sector where dedicated research is less common than among the largest-cap peers. Investors tracking personal care stocks should add this company to their research watchlist only after verifying data on NSE or BSE.

Key Risk

Key Risk for this personal care stocks: Stationery market growth is structurally pressured by increasing digital note-taking, tablet adoption in schools, and declining physical art usage among younger cohorts. The core school stationery market that Camlin dominates faces long-term volume headwinds as classroom digitisation accelerates. Cross-verify risks among all personal care stocks before drawing conclusions.

Download the Univest iOS App or Univest Android App to track live personal care fmcg prices and get daily research.

Quick Comparison: 5 Under-the-Radar Stocks at a Glance

The table below summarises each company's standout attribute and primary risk for quick reference. This is a research shortlist, not a ranking.

Stock Standout Attribute Key Metrics Primary Risk
Honasa Consumer D/E 0.01 (near-zero debt) PE 50.0, ROE 8.0%, D/E 0.01 Honasa's PE of 50 requires sustained growth to justify.
Zydus Wellness D/E 0.01 (near-zero debt) PE 40.0, ROE 18.0%, D/E 0.01 The energy drink and nutrition segment has significant competition from Horlicks (HUL), Bournvita (Mondelez), and newer brands.
Gillette India 40.0% ROE PE 45.0, ROE 40.0%, D/E 0.01 Gillette India's listing makes it an expensive subsidiary with limited growth optionality independent of P&G global decisions.
P&G Hygiene and Health Care 50.0% ROE PE 60.0, ROE 50.0%, D/E 0.01 P&G Hygiene's valuation (PE 60) reflects its near-monopoly brand positioning but leaves minimal margin for growth shortfalls.
Kokuyo Camlin MCap Rs 1,320 Cr, lower coverage PE 25.0, ROE 10.0%, D/E 0.10 Stationery market growth is structurally pressured by increasing digital note-taking, tablet adoption in schools, and declining physical art usage among younger cohorts.

Why Do These Personal Care FMCG Stocks Receive Comparatively Lower Coverage?

Lower trading volumes further reduce interest from momentum traders, keeping news flow consistently thin. Historically, some of India's strongest multi-year compounding has originated from exactly this kind of overlooked ground , when a cycle shift or earnings re-rating forces the broader market to reassess what the fundamentals already indicated. That said, low coverage is neither a guarantee of outperformance nor a signal of undervaluation on its own.

What Factors Should Investors Evaluate in Personal Care Lesser-Known Personal Care FMCG Stocks?

  • Return on equity: Look for ROE consistently above 12-15% across multiple reporting periods, not just peak-cycle years. High and consistent ROE signals capital efficiency that PE screens alone cannot capture.
  • Debt-to-equity ratio: Low D/E provides operational runway to survive a difficult year without equity dilution or asset sales. A D/E below 0.30 is generally considered low leverage for non-financial companies.
  • PE relative to sector PE: A discount to sector PE is only meaningful if business quality supports the comparison. Always check the current sector PE on NSE or BSE and pair this with ROE and D/E data.
  • Revenue and profit growth: Consistent revenue growth over three to five years is more meaningful than a single strong year. Check the quarterly results section on NSE (nseindia.com) for the complete trend.
  • Promoter holding: Stable or increasing promoter holding often signals confidence in the business outlook. Significant promoter selling should prompt additional scrutiny. Check the latest shareholding disclosure on NSE or BSE before investing.
  • Consistency over multiple years: A single exceptional year of high ROE or low D/E can be misleading. Look for patterns across 3-5 years of annual reports. Companies with consistent financial characteristics tend to be structurally sound rather than cyclically lucky. Annual reports are available on the respective company investor relations pages and on NSE and BSE.

Key Risks to Evaluate in Under-the-Radar Personal Care FMCG Stocks

  • Valuation compression: Several stocks on this list carry PE multiples above 40x, embedding growth expectations that require consistent execution. Any earnings miss against these expectations can cause disproportionate share-price corrections.
  • Low trading liquidity: Smallcap personal care fmcg stocks can move sharply on modest volumes. Building or exiting a large position without meaningful market impact can be challenging in lower-volume names.
  • Input-cost inflation: Many personal care fmcg companies face raw material cost volatility. A sudden spike in input prices without the pricing power to pass through costs can rapidly compress margins.
  • Earnings cyclicality: Smallcap companies tend to deliver less stable quarter-on-quarter earnings growth than large caps. Investors must be prepared for wider swings in reported profits, sometimes within the same financial year.
  • Competitive intensity: Larger sector players with established distribution, brand recall, and balance-sheet strength can pressure smaller companies' market share in a downturn.

How to Research and Invest in Personal Care Stocks in India

Start with the business model. Each of the five companies on this list operates differently, and position sizing should reflect the specific risk-return profile of each rather than treating them as a uniform group.

Verify independently. All figures in this article are based on publicly available NSE and BSE data as of 23 August 2026. Always check the latest quarterly results, annual reports, and shareholding disclosures on nseindia.com or bseindia.com before investing.

Use a screener to compare. The Univest Screener allows investors to apply PE, ROE, and D/E filters on live market data to build a comparison shortlist across the personal care fmcg sector.

Diversify across names where relevant. Concentrating entirely in one smallcap personal care stocks amplifies single-stock event risk. Spreading exposure across two or three names where the thesis is independently sound reduces that risk meaningfully. Consult a SEBI-registered investment advisor to align any investment with your personal financial goals.

Track earnings trends, not just a point-in-time snapshot. The metrics shown in this article reflect data as of 23 August 2026. These figures will change with each quarterly result. Building a simple trend view across three to five recent quarters tells you far more about business direction than any single set of current figures. NSE's quarterly results archive is a free, comprehensive primary source for this data. Combine it with the company's own investor presentations where available.

Key Takeaways on Personal Care Stocks

  • The five personal care stocks covered here represent a range of market caps and business models within the personal care sector.
  • Each of these personal care stocks has been selected based on publicly available fundamental data as of 23 August 2026.
  • Investors researching personal care stocks should verify all figures on NSE or BSE directly before making any decision.
  • The personal care sector has more depth than the top three names. These personal care stocks are the starting point for broader exploration.
  • No personal care stocks selection is permanent. Review the thesis quarterly as new fundamental data becomes available.

Conclusion

The five personal care stocks companies covered in this article , Honasa Consumer (D/E 0.01), Zydus Wellness (D/E 0.01), Gillette India (ROE 40.0%), P&G Hygiene and Health Care (ROE 50.0%), and Kokuyo Camlin (D/E 0.10) , each present a distinct profile. They are not identical in their risk-return characteristics, their stage of development, or the reason they receive comparatively lower institutional attention. Investors researching personal care stocks in India should evaluate each company independently using its own financial history, management track record, and position within the sector before drawing any conclusion.

None of the companies in this article are presented as buy recommendations. The personal care sector carries market, operational, and valuation risks that affect each of these five companies differently. Please consult a SEBI-registered investment advisor before making any investment decision.

Disclaimer: Data and figures in this article are sourced from publicly available NSE and BSE information. These may or may not be accurate. Please verify all data with NSE (nseindia.com) and BSE (bseindia.com) before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Under the Radar Personal Care Stocks

Which personal care stocks are flying under the radar in India?

Ans. Five personal care stocks that receive comparatively lower institutional coverage in India are Honasa Consumer, Zydus Wellness, Gillette India, P&G Hygiene and Health Care, and Kokuyo Camlin. Each has a different fundamental profile. Treating these personal care stocks as research starting points, not buy signals, is advisable. Verify all data on NSE or BSE before investing.

Are smallcap personal care stocks suitable for long-term investment?

Ans. Smallcap personal care stocks can offer higher potential returns than large-cap peers in a favourable cycle, but they also carry greater risks: lower liquidity, limited analyst coverage, and higher earnings volatility. Each of the five stocks covered here should be evaluated on its own financial merits and risk profile. Consult a SEBI-registered advisor before investing.

What are the key metrics to check in personal care stocks?

Ans. Key metrics include PE ratio (compared against the current sector PE on NSE or BSE), ROE (ideally above 12-15% consistently), D/E ratio (lower is generally safer for non-financial companies), revenue growth trend, and promoter holding. No single metric should be used in isolation.

Is Honasa Consumer a good stock to research?

Ans. Honasa Consumer has a PE of 50.00 and an ROE of 8.00%, with a D/E of 0.01 and a 52-week range of Rs 243.0 to Rs 397.0. These metrics are worth evaluating against the sector average and the company's own historical performance. Verify all data on NSE before investing.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down